Viewing nowAnarika Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Aju Pharmaceuticals Co., Ltd.

MFDS item code 201109277 · Approved 2011.10.31 · Insurance code 654004050
Treatment of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, relief of fibromyalgia.
This medication is used to relieve pain caused by peripheral and central neuropathy in adults. It is also utilized as an adjunctive treatment for partial seizures in patients with epilepsy, either with or without secondary generalized symptoms. Additionally, it is effective in reducing muscle pain and discomfort due to fibromyalgia. This way, it helps to manage various neurological disorders and pain, contributing to the improvement of patients' quality of life.
This medication should be taken orally by dividing the total daily dosage into two doses, regardless of food intake. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose of 150 mg per day can be increased to up to 300 mg within 3 to 7 days, and if necessary, can be increased up to a maximum of 600 mg per day. - Central Neuropathic Pain: Starting dose of 150 mg per day can be increased to 300 mg per day after one week.
This medication may increase the risk of suicidal thoughts or behaviors, so any symptoms or mood changes should be reported to healthcare professionals immediately during treatment. This medication should not be used by those who are allergic to its ingredients, and patients with specific genetic conditions such as lactose intolerance should also avoid it. Patients with diabetes should be cautious as weight gain from this medication may require adjustment of blood sugar control medication doses. If symptoms of angioedema, such as swelling of the face or around the mouth, appear due to hypersensitivity, the medication should be stopped immediately. Elderly patients may be at risk of falling or injury due to dizziness or drowsiness from this medication, so they should be especially careful during initial dosing. Some patients may experience blurred vision or changes in eyesight, and if such symptoms appear, they should consult healthcare professionals. There may be cases where other antiepileptic drugs are stopped before using this medication, but there is insufficient data on this, so caution should be taken in administration. Abrupt discontinuation of the medication can lead to withdrawal symptoms such as insomnia, headache, anxiety, depression, and suicidal thoughts, so it should be tapered off gradually under medical supervision. Due to the risk of drug abuse, patients with a history of mental illness or drug abuse should be particularly cautious, and monitoring for unusual behavior is necessary. Patients with renal impairment may need dose adjustments, and those with heart disease should also be treated with caution. Caution is advised when using this medication with opioid analgesics, as central nervous system depression may be more pronounced. Drowsiness and dizziness may occur during treatment, so it is advisable to avoid driving or operating dangerous machinery. Early in pregnancy, there is a risk of fetal malformations, so pregnant women are advised not to take this medication, and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing this medication, as it can be excreted in breast milk and affect the infant. In case of an overdose, confusion, drowsiness, seizures, etc., may occur, and immediate medical attention should be obtained. This medication should be kept out of reach of children, and transferring it to another container may lead to quality deterioration or accidents, so it should be avoided.
Rash, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best to store it at room temperature between 15 and 30 degrees Celsius. This storage will help maintain the efficacy of the medication.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder that is white or pale yellow.
Domestic - 30 capsules/bottle, Export - 30 capsules/box [10 capsules/PTP*3], Export - 100 capsules/box [10 capsules/PTP*10]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.